Vimarsana
Biggest News Aggregation in the World

Mid Second Half News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mid Second Half. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mid Second Half Today - Breaking & Trending Today

Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update

Published: August 10, 2022

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

Source: prnewswire.com
Related Topics:
Ji XingUnited StatesDavid PittsJoseph OlivetoBruce StamblerSean PokorneyDuke University School Of MedicineJi Xing Pharmaceuticals LimitedArrhythmia Core LaboratoryCompany Remains On Track To ReportMilestone Pharmaceuticals IncCenters For DiseaseUs Securities Exchange CommissionArrhythmia ResearchHeart Rhythm SocietyAmerican College Of CardiologyPiedmont Heart InstituteJi Xing PharmaceuticalsDrug AdministrationDuke Clinical Research InstituteExchange CommissionMilestone PharmaceuticalsChief Executive OfficerRequired NumberDouble Blind Study Medication
Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update

Published: August 10, 2022

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

Source: prnewswire.com
Related Topics:
Ji XingUnited StatesDavid PittsJoseph OlivetoBruce StamblerSean PokorneyDuke University School Of MedicineJi Xing Pharmaceuticals LimitedArrhythmia Core LaboratoryCompany Remains On Track To ReportMilestone Pharmaceuticals IncCenters For DiseaseUs Securities Exchange CommissionArrhythmia ResearchHeart Rhythm SocietyAmerican College Of CardiologyPiedmont Heart InstituteJi Xing PharmaceuticalsDrug AdministrationDuke Clinical Research InstituteExchange CommissionMilestone PharmaceuticalsChief Executive OfficerRequired NumberDouble Blind Study Medication
Milestone Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Corporate Update

Published: May 12, 2022

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

Source: prnewswire.com
Related Topics:
United StatesDavid BharuchaDavid PittsJoseph OlivetoBruce StamblerSean PokorneyDuke University School Of MedicineMontreal Heart InstituteArrhythmia Core LaboratoryPrnewswire Milestone Pharmaceuticals IncCenters For DiseaseUs Securities Exchange CommissionMilestone Pharmaceuticals IncArrhythmia ResearchHeart Rhythm SocietyAmerican College Of CardiologyPiedmont Heart InstituteDuke Clinical Research InstituteExchange CommissionMilestone PharmaceuticalsChief Executive OfficerHeart RhythmReport Topline DataMid Second HalfNew Drug Application
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update

Published: March 24, 2022

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

Source: prnewswire.com
Related Topics:
United StatesDavid BharuchaDavid PittsJoseph OlivetoMilestone Pharmaceuticals IncUs Securities Exchange CommissionMontreal Heart InstituteCenters For DiseaseAmerican Heart AssociationCompany On Twitter At MilestonepharmaAmerican College Of CardiologyExchange CommissionMilestone PharmaceuticalsChief Executive OfficerReport Topline DataMid Second HalfNew Drug ApplicationClinical Analysis EvaluatingDrug CharacteristicsAmerican CollegeAnnual Scientific SessionIntranasal EtripamilHealthy JapaneseChief MedicalRate Data